Fig. 2. C-M

Edwards-Faret G et al. (2021)

Xla Wt + spinal cord amputation

NF50 + 2 dpt ( immunohistochemistry)

Expression Phenotype

increased amount ascl1.L expression in spinal cord
increased amount aldh1l1.L expression in spinal cord
increased amount dcx.L expression in spinal cord
increased amount mbp.L expression in spinal cord
increased amount nes.L expression in spinal cord
increased amount neurod1.L expression in spinal cord
increased amount neurog2.L expression in spinal cord
increased amount neurog3.L expression in spinal cord
increased amount sox10.L expression in spinal cord
increased amount sox2.L expression in spinal cord
increased amount vim.L expression in spinal cord

Fig. 6 C-M

Edwards-Faret G et al. (2021)

Xla Wt + spinal cord amputation

NF50 + 6 dpt (immunohistochemistry)

Expression Phenotype

increased amount ascl1.L expression in spinal cord
decreased amount mbp.L expression in spinal cord
decreased amount sox10.L expression in spinal cord
increased amount aldh1l1.L expression in spinal cord
increased amount dcx.L expression in spinal cord
increased amount nes.L expression in spinal cord
increased amount neurog2.L expression in spinal cord
increased amount neurog3.L expression in spinal cord
increased amount sox2.L expression in spinal cord
increased amount vim.L expression in spinal cord

fig.4.r

Xue XY and Harris WA (2012)

Xla Wt + myc MO

NF28 (in situ hybridization)

Expression Phenotype
decreased amount ascl1.L expression in eye decreased amount ascl1.L expression in midbrain-hindbrain boundary

fig.4.t

Xue XY and Harris WA (2012)

Xla Wt + mycn MO

NF28 (in situ hybridization)

Expression Phenotype
decreased amount ascl1.L expression in eye decreased amount ascl1.L expression in midbrain-hindbrain boundary